• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

NORTRIPTYLINE Drug Record

  • Summary
  • Interactions
  • Claims
  • NORTRIPTYLINE chembl:CHEMBL445 Approved

    Alternate Names:

    MOTIPRESS
    MOTIVAL
    NCI-169453
    AVENTYL
    PAMELOR
    ALLEGRON
    NORTRIPTYLINE
    NORITREN
    10,11-DIHYDRO-N-METHYL-5H-DIBENZO[A,D]CYCLOHEPTENE-DELTA(5,GAMMA)-PROPYLAMINE
    PSYCHOSTYL
    DESMETHYLAMITRIPTYLINE
    PAMELOR®
    SENSAVAL
    3-(10,11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTEN-5-YLIDENE)-N-METHYL-1-PROPANAMINE
    DEMETHYLAMITRIPTYLINE
    ATEBEN
    AVENTYL®
    AVANTYL
    NORTRIPTYLINE HYDROCHLORIDE
    pubchem.compound:4543
    chembl:CHEMBL445
    chemidplus:72-69-5
    drugbank:00540
    rxcui:7531

    Drug Info:

    Year of Approval approved before 1982
    Drug Class antidepressive agents, tricyclic
    Drug Indications antidepressant
    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications antiasthmatic agent
    (3 More Sources)

    Publications:

    Roberts RL et al., 2002, A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression., Pharmacogenomics J
    Barker et al., 1996, Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter., Mol. Pharmacol.
    Roubert et al., 2001, A Na(+)/Cl(-)-dependent transporter for catecholamines, identified as a norepinephrine transporter, is expressed in the brain of the teleost fish medaka (Oryzias latipes)., Mol. Pharmacol.
    Tatsumi et al., 1997, Pharmacological profile of antidepressants and related compounds at human monoamine transporters., Eur. J. Pharmacol.
    Roubert et al., 2001, Determination of residues in the norepinephrine transporter that are critical for tricyclic antidepressant affinity., J. Biol. Chem.
    Vaishnavi et al., 2004, Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity., Biol. Psychiatry
    Kim et al., 2006, Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression., JAMA
    Rausch et al., 2003, Initial platelet serotonin (5-HT) transport kinetics predict nortriptyline treatment outcome., J Clin Psychopharmacol
    Joyce et al., 2003, Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline., Int. J. Neuropsychopharmacol.
    Wisner et al., 2006, Postpartum depression: a randomized trial of sertraline versus nortriptyline., J Clin Psychopharmacol
    Pollock et al., 2000, Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression., Neuropsychopharmacology
    Keers R et al., 2011, Variation in GNB3 predicts response and adverse reactions to antidepressants., J Psychopharmacol
    Perroud N et al., 2009, Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project., Neuropsychopharmacology
    Lin E et al., 2015, Genome-wide association studies in pharmacogenomics of antidepressants., Pharmacogenomics
    Uher R et al., 2010, Genome-wide pharmacogenetics of antidepressant response in the GENDEP project., Am J Psychiatry
    Malki K et al., 2011, Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants., Biol Psychiatry
  • NORTRIPTYLINE   UST

    Interaction Score: 16.86

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    25916525 20360315


    Sources:
    PharmGKB

  • NORTRIPTYLINE   SLC39A14

    Interaction Score: 11.24

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    20970119


    Sources:
    PharmGKB

  • NORTRIPTYLINE   SLC6A2

    Interaction Score: 1.15

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name CRx-170
    Novel drug target Established target
    Trial Name CRx-191

    PMIDs:
    8863842 11502876 9537821 11092898 14744476 17018806


    Sources:
    TdgClinicalTrial TEND

  • NORTRIPTYLINE   GNB3

    Interaction Score: 0.86

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    20826553


    Sources:
    PharmGKB

  • NORTRIPTYLINE   SLC6A4

    Interaction Score: 0.86

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name CRx-191
    Novel drug target Established target
    Trial Name CRx-170

    PMIDs:
    12640215 9537821 14744476 14604448 16855451 11027924


    Sources:
    TdgClinicalTrial TEND

  • NORTRIPTYLINE   BDNF

    Interaction Score: 0.18

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    19641488


    Sources:
    PharmGKB

  • NORTRIPTYLINE   ABCB1

    Interaction Score: 0.05

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    12082591


    Sources:
    PharmGKB

  • NORTRIPTYLINE   DRD1

    Interaction Score: 0.04

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • NORTRIPTYLINE   ATXN2

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • NORTRIPTYLINE   CYP2D6

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC FDA

  • NORTRIPTYLINE   TP53

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • TEND: NORTRIPTYLINE

    • Version: 01-August-2011

    Alternate Names:
    NORTRIPTYLINE Primary Drug Name

    Drug Info:
    Drug Class antidepressive agents, tricyclic
    Year of Approval approved before 1982

    Publications:

  • TdgClinicalTrial: NORTRIPTYLINE

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antiasthmatic agent
    Drug Class Small Molecule
    FDA Approval approved

    Publications:

  • PharmGKB: nortriptyline

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:
    Perroud N et al., 2009, Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project., Neuropsychopharmacology
    Roberts RL et al., 2002, A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression., Pharmacogenomics J
    Keers R et al., 2011, Variation in GNB3 predicts response and adverse reactions to antidepressants., J Psychopharmacol

  • TTD: Nortriptyline

    • Version: 2020.06.01

    Alternate Names:
    D04WFD TTD Drug ID

    Drug Info:

    Publications:

  • DTC: NORTRIPTYLINE

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL445 ChEMBL Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL445

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • FDA: Nortriptyline

    • Version: 04-September-2020

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21